Upcoming Events
  1. ALTG open MAC and SAC meetings

    November 20
  2. Virtual 2020 World Conference on Lung Cancer Singapore

    January 28, 2021 @ 8:00 am - January 31, 2021 @ 5:00 pm

Thoracic oncology highlights from ASCO2020 webinar- recording and evaluation survey

Please fill in the evaluation survey if you have not already done so by clicking on the survey icon at the base of your webinar console.

Please access the recording and evaluation survey here

ALTG awarded $12 million in funding

The ALTG is pleased to announce over $12 million in funding has been successfully awarded to ALTG, NHMRC Clinical Trial Centre and the Australian Genomic Cancer Medicine Centre for the ASPiRATION project. In this ground-breaking precision medicine study, led by ALTG President A/Prof Nick Pavlakis and ALTG Scientific Advisory Committee Chair, Prof Ben Solomon, ASPiRATION will explore the benefit of routine comprehensive genomic profiling in 1000 newly-diagnosed metastatic, non-squamous, NSCLC patients in Australia. The enhanced genomic profiling will assist in personalising patient care by matching patients to targeted treatments as early as possible to improve patient outcomes.

ALTG 16/011 CORE: Conventional care Or Radioablation for Extracranial metastases – F Foroudi

TROG 16.03 was approved by HREC, December 13, 2016 for the following eight sites: Princess Alexandra Hospital, Royal Brisbane and Women’s Hospital, Austin Health, Peter MacCallum Cancer Centre, Calvary Mater Newcastle, Westmead Hospital, Liverpool Hospital, & Royal Adelaide Hospital. Approved sites are now in the process of submitting to their RGO. The Quality Assurance program for Australian sites is still in development and the expected activation date is June 2017 if not earlier.